Overview Nobivac® Canine 1-DAPPV + CV is shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus, canine parvovirus and canine coronavirus.

  • Recommended for use in healthy dogs 6 weeks of age or older
  • Proven effective against all known strains of canine parvovirus (CPV), including CPV-2c1-®3
  • Contains CPV-2b, one of the most prevalent field strains of parvovirus
  • High antigenic mass (titer), low passage parvovirus vaccine
  • Overrides maternal antibodies in young puppies1
  • Proven effective against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
  • Vaccinate only healthy, non-parasitized dogs
  • Do not vaccinate pregnant dogs